Fundings

Current fundings

As Coordinator: ANR SerozeroSEP (2022-2026, 240 k€ for team), CEFIPRA (2023-2027, 100k€), Ligue contre le cancer (AAP Douleur: 2022-2026, 190 k€ and AAP2025, 30 k€), APR-IR TheraSEP (2022-2026, 115 k€), InflamaMiR (2026-2029, 175 k€) Prématuration CNRS NovalSEPia (2026-2027, 70k€), EPSM, 2024-2027, 40 k€; 2PhD student, 220k€)

As Partner :ANR Polyther (2024-2028, 240 k€), ANR Peptazafluo (2024-2028, 18 k€), ANR Papaud (2023-2026)

Previous fundings: ARSLA, ARSEP, FRM, Ligue, APR-IR (Serozero7, Pain), Europe (FEDER GlioMab), C-VALO